Novartis Acquires Endocyte for $2.1 Billion

Novartis will benefit from the acquisition by expanding its radioligand therapy platform, while Endocyte and its...

October 18th, 2018

Abbvie’s Humira Faces Biosimilar Competition

The long wait for Biogen’s European launch of Imraldi was due to its legal battle with...

October 18th, 2018

resTORbio Releases Additional Trial Data

Months after releasing initial positive topline data for its Phase 2b trial of RTB101, resTORbio provided...

October 17th, 2018

Biotech Stocks in 2018

 
Find out how the market will look this year

Oragenics Receives Approval for Phase 2 Study

Oragenics announced Wednesday that it has been approved in Belgium to enroll patients in a Phase...

October 17th, 2018

Biotech Update: Q3 2018 in Review

With the first three quarters of 2018 over, the Investing News Network is reviewing top news...

October 15th, 2018

Biotech Stocks in 2018

 
Find out how the market will look this year

5 Top Weekly NASDAQ Biotech Stocks: MannKind Leads the...

MannKind, Sierra Oncology, Eiger BioPharmaceuticals, Aevi Genomic Medicine and KalVista Pharmaceuticals were last week's top gainers...

October 14th, 2018

5 Top NASDAQ Biotech Stocks Year-to-Date

With Q3 over and Q4 already underway, here the Investing News Network looks at the top-gaining...

October 10th, 2018
<< Older Posts
On the most fundamental level, biotechnology is any technology or product developed using cellular and biomolecular processes. That means products as simple as bread and cheese could be considered biotech innovations — albeit very simple ones. Today, the biotech field has expanded substantially, and those involved in it are making significant strides towards solving some of the world’s greatest problems. The majority of biotech companies are engaged in the long-term research and development of new medicines and vaccinations. However, the field extends well beyond this focus on healthcare. From increasing agricultural efficiency in order to feed the world’s hungry to developing biofuels to reduce the energy required for manufacturing, the industry is diverse and rapidly expanding, with multiple opportunities for...

On the most fundamental level, biotechnology is any technology or product developed using cellular and biomolecular processes. That means products as simple as bread and cheese could be considered biotech innovations — albeit very simple ones. Today, the biotech field has expanded substantially, and those involved in it are making significant strides towards solving some of the world’s greatest problems.

The majority of biotech companies are engaged in the long-term research and development of new medicines and vaccinations. However, the field extends well beyond this focus on healthcare. From increasing agricultural efficiency in order to feed the world’s hungry to developing biofuels to reduce the energy required for manufacturing, the industry is diverse and rapidly expanding, with multiple opportunities for biotech investing.

Preventing, fighting and curing disease

The biotech industry is most widely recognized for its contributions to healthcare. Biotech innovations have the potential to extend and save lives through the early detection of diseases, the development of preventative medications and the treatment of serious, life-threatening illnesses.

The Biotechnology Industry Organization calculates that the biotech industry has made more than 250 healthcare products and vaccines available to patients, transforming our understanding of international health and the financial implications of these illnesses. For example, according to the industry report Healing, Fueling, Feeding: How Biotechnology Is Enriching Your Life, the US spends approximately $2 billion annually treating cervical cancer. The report estimates that a concerted national vaccination campaign promoting the vaccines Gardasil® (Merck & Co. (NYSE:MRK)) and Cervarix® (GlaxoSmithKline (LSE:GSK,NYSE:GSK)) could save the healthcare system up to $1.4 billion per year, in addition to thousands of lives.

Feeding and fueling the future

All that said, healthcare isn’t the only sector that benefits from investment in the biotech industry. In fact, it’s helping fields all over the world be farmed more efficiently. Specifically, biotech helps farmers grow crops with fewer inputs, less chemicals and increased nutrition profiles. According to the Healing, Fueling, Feeding report, there was a 25-fold increase in the number of acres being farmed with biotech crops between 1996 and 2000. By 2009, this number increased to 330 million acres of biotech crops grown in 25 countries by 14 million individual farmers.

Biotech can also increase efficiency in manufacturing by halving the energy required in certain manufacturing processes and decreasing the steps involved in creating particular chemicals by up to 80 percent. These innovations will decrease dependence on foreign oil by making a sustainable, bio-based economy a viable alternative.

Numbers don’t lie

If medical biotech helps to create healthier lives, industrial biotech makes advances towards creating a healthier, more efficient Earth. Biotech offers the opportunity to invest in tangible solutions for national imperatives as diverse as public health, economic security and environmental sustainability.

All of those benefits make the biotech industry a popular choice amongst investors. Indeed, according to PricewaterhouseCoopers’ MoneyTree Life Sciences Report, the biotech industry was the second-largest investment destination in terms of dollars in 2014. With $6 billion invested in 470 deals in the past year, biotech investment appears to be a very promising investment in the future.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time